Pavlova T V, Poliakov V P, Dupliakov D V, Khokhlunov S M, Kirillov V I, Shavkunov S A
Kardiologiia. 2009;49(4):9-13.
We have studied structure of polymorphisms of genes of blood clotting factors II, V, VII, platelet membrane glycoprotein IIIa (GPIIIa) and enzyme methylenetetrahydrofolate reductase (MTHFR) in patients with ischemic heart disease (IHD). In this cohort of patients most prevalent are polymorphism PLAA1/A2 of GPIIIa gene and 677T/T polymorphism of MTHFR gene. Inconsistency of existing evidence on effect of R/Q genotype of FVII gene on early development of IHD and myocardial infarction (MI) is underlined, and data on the absence of protective effect of Q allele on early development of MI are presented. Activating effect of PLAA1/A2 polymorphism of GPIIIa gene and 677T/T polymorphism of MTHFR gene on morphofunctional state of platelets is proved.
我们研究了缺血性心脏病(IHD)患者凝血因子II、V、VII、血小板膜糖蛋白IIIa(GPIIIa)和亚甲基四氢叶酸还原酶(MTHFR)基因多态性的结构。在这组患者中,最常见的是GPIIIa基因的PLAA1/A2多态性和MTHFR基因的677T/T多态性。强调了关于FVII基因R/Q基因型对IHD早期发展和心肌梗死(MI)影响的现有证据不一致,并给出了关于Q等位基因对MI早期发展无保护作用的数据。证明了GPIIIa基因的PLAA1/A2多态性和MTHFR基因的677T/T多态性对血小板形态功能状态的激活作用。